SUPN - Supernus Pharmaceuticals Inc Revenue Breakdown

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: INDV ALKS AMRX KNSA LNTH NBIX ACAD TLX BIIB VRTX

| Held by: IJR VTI IWM VB VBR VXF SPSM IWN IJT VTWO

Scroll to Statements

Index	RUT
Market Cap	2.69B
Enterprise Value	2.36B
Income	-109.89M
Sales	830.44M
Book/sh	17.73
Cash/sh	6.40
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	778
IPO	May 01, 2012

P/E	-
Forward P/E	9.93
PEG	0.53
P/S	3.24
P/B	2.61
P/C	7.22
P/FCF	143.04
EV/EBITDA	62.79
EV/Sales	2.84
Quick Ratio	1.84
Current Ratio	2.08
Debt/Eq	0.04
LT Debt/Eq	0.03
Option/Short	Yes / Yes

EPS (ttm)	-1.91
EPS next Y	4.66
EPS next Q	0.68
EPS this Y	-13.44%
EPS next Y	66.25%
EPS next 5Y	18.63%
EPS past 3/5Y	- -
Sales past 3/5Y	2.52% 6.68%
EPS Y/Y TTM	-264.42%
Sales Y/Y TTM	24.85%
EPS Q/Q	-353.07%
Sales Q/Q	32.40%
Earnings	Aug 03 BMO
EPS/Sales Surpr.	24.52% 6.70%

Insider Own	6.20%
Insider Trans	-4.80%
Inst Own	99.44%
Inst Trans	-0.54%
ROA	-7.82%
ROE	-10.49%
ROIC	-10.36%
Gross Margin	75.83%
Oper. Margin	-7.73%
Profit Margin	-13.23%
SMA20	-1.39%
SMA50	0.16%
SMA200	-5.55%
Trades

Shs Outstand	58.16M
Shs Float	54.44M
Short Float	8.91%
Short Ratio	5.63
Short Interest	4.85M
52W High	59.68 -22.52%
52W Low	36.46 26.82%
Volatility	7.61% 4.57%
ATR (14)	2.27
RSI (14)	49.09
Beta	0.55
Rel Volume	1.01
Avg Volume	861.06K
Volume	79,690

Perf Week	-0.71%
Perf Month	-3.55%
Perf Quarter	-6.00%
Perf Half Y	-4.46%
Perf YTD	-6.96%
Perf Year	23.21%
Perf 3Y	43.69%
Perf 5Y	73.90%
Perf 10Y	100.09%
Recom	1.50
Target Price	62.50
Prev Close	43.25
Price	46.24
Change	6.91%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)